Cargando…

The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study

BACKGROUND AND OBJECTIVES: Gastric cancer is known as one of the most common cancers and causes of deaths. Early and proper diagnosis is one of the most important things for treatment response. Therefore, this study aimed to determine the expression of p53, CD44, Ki-67, and HER-2/neu markers in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahadi, Mahsa, Moradi, Afshin, Musavinejad, Leila, Movafagh, Abolfazl, Moradi, Arsham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568877/
https://www.ncbi.nlm.nih.gov/pubmed/32592354
http://dx.doi.org/10.31557/APJCP.2020.21.6.1607
_version_ 1783596612087447552
author Ahadi, Mahsa
Moradi, Afshin
Musavinejad, Leila
Movafagh, Abolfazl
Moradi, Arsham
author_facet Ahadi, Mahsa
Moradi, Afshin
Musavinejad, Leila
Movafagh, Abolfazl
Moradi, Arsham
author_sort Ahadi, Mahsa
collection PubMed
description BACKGROUND AND OBJECTIVES: Gastric cancer is known as one of the most common cancers and causes of deaths. Early and proper diagnosis is one of the most important things for treatment response. Therefore, this study aimed to determine the expression of p53, CD44, Ki-67, and HER-2/neu markers in the gastric cancer and its relationship with histopathological indicators. METHODS: This is a descriptive-analytical study on 60 patientsts with cancer who underwent gastrectomy surgery in 2011-2016 in Shohadaye Tajrish Hospital. The participants were investigated for p53, CD44, Ki-67, and HER-2/neu markers’ staining plus demographic characteristics, rate of survival, and histopathological features of the tumors. RESULTS: The mean age of the participants (44 males and 16 females) was 60.25±1.29 years. The patients’ survival rate was 23.82±1.56 months on average. The tumor size was reported as 6.09±2.61 cm and the major tumor type reported was intestinal type (n=40, 66.7%). The level of expression of Ki-67 and CD44 makers was recorded as 33.75 and 24.50%, and p53 and HER-2/neu immunostains were positive in 25 (41.7%) and 20 (33.3%) patients, respectively. The expression of p53 and CD44 markers had no significant relationship with the demographic characteristics, rate of survival, and histopathological features of the tumor of patients (all p>0.05). The expression of p53 gene was associated with a lower rate of survival (p=0.014), while the expression of HER-2/neu was associated with higher probability of developing intestinal type of stomach adenocarcinoma (p=0.010) and ulcerative macroscopic view (p=0.034). CONCLUSION: This study illustrated that p53 and CD44 markers did not have any diagnostic value in predicting the biological behavior of gastric cancer. In fact, incidence of p53 mmunoreactivity was associated with the lower rate of survival, and the expression of HER-2/neu was associated with higher probability of developing the intestinal type of stomach adenocarcinoma and ulcerative macroscopic view.
format Online
Article
Text
id pubmed-7568877
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-75688772020-10-30 The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study Ahadi, Mahsa Moradi, Afshin Musavinejad, Leila Movafagh, Abolfazl Moradi, Arsham Asian Pac J Cancer Prev Research Article BACKGROUND AND OBJECTIVES: Gastric cancer is known as one of the most common cancers and causes of deaths. Early and proper diagnosis is one of the most important things for treatment response. Therefore, this study aimed to determine the expression of p53, CD44, Ki-67, and HER-2/neu markers in the gastric cancer and its relationship with histopathological indicators. METHODS: This is a descriptive-analytical study on 60 patientsts with cancer who underwent gastrectomy surgery in 2011-2016 in Shohadaye Tajrish Hospital. The participants were investigated for p53, CD44, Ki-67, and HER-2/neu markers’ staining plus demographic characteristics, rate of survival, and histopathological features of the tumors. RESULTS: The mean age of the participants (44 males and 16 females) was 60.25±1.29 years. The patients’ survival rate was 23.82±1.56 months on average. The tumor size was reported as 6.09±2.61 cm and the major tumor type reported was intestinal type (n=40, 66.7%). The level of expression of Ki-67 and CD44 makers was recorded as 33.75 and 24.50%, and p53 and HER-2/neu immunostains were positive in 25 (41.7%) and 20 (33.3%) patients, respectively. The expression of p53 and CD44 markers had no significant relationship with the demographic characteristics, rate of survival, and histopathological features of the tumor of patients (all p>0.05). The expression of p53 gene was associated with a lower rate of survival (p=0.014), while the expression of HER-2/neu was associated with higher probability of developing intestinal type of stomach adenocarcinoma (p=0.010) and ulcerative macroscopic view (p=0.034). CONCLUSION: This study illustrated that p53 and CD44 markers did not have any diagnostic value in predicting the biological behavior of gastric cancer. In fact, incidence of p53 mmunoreactivity was associated with the lower rate of survival, and the expression of HER-2/neu was associated with higher probability of developing the intestinal type of stomach adenocarcinoma and ulcerative macroscopic view. West Asia Organization for Cancer Prevention 2020-06 /pmc/articles/PMC7568877/ /pubmed/32592354 http://dx.doi.org/10.31557/APJCP.2020.21.6.1607 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ahadi, Mahsa
Moradi, Afshin
Musavinejad, Leila
Movafagh, Abolfazl
Moradi, Arsham
The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
title The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
title_full The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
title_fullStr The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
title_full_unstemmed The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
title_short The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study
title_sort expression of p53, cd44, ki-67, and her-2/neu markers in gastric cancer and its association with histopathological indicators: a retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568877/
https://www.ncbi.nlm.nih.gov/pubmed/32592354
http://dx.doi.org/10.31557/APJCP.2020.21.6.1607
work_keys_str_mv AT ahadimahsa theexpressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT moradiafshin theexpressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT musavinejadleila theexpressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT movafaghabolfazl theexpressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT moradiarsham theexpressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT ahadimahsa expressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT moradiafshin expressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT musavinejadleila expressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT movafaghabolfazl expressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy
AT moradiarsham expressionofp53cd44ki67andher2neumarkersingastriccanceranditsassociationwithhistopathologicalindicatorsaretrospectivestudy